Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
February 5, 2016

Recent Stories

From Drug Benefit News - CMS on Jan. 21 posted a long-awaited final rule implementing Affordable Care Act-mandated changes to the Medicaid Drug Rebate Program, including the calculation of average manufacturer price (AMP) and its use to determine reimbursement for generic covered outpatient drugs. Read more

In an effort to more closely align pharmaceutical cost with drug efficacy,… Read more

During a recent presentation at the 34th Annual J.P. Morgan Healthcare Conference,… Read more

The Centers for Disease Control and Prevention last month unveiled some disturbing… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

February 8, 2016
Cigna, Novartis Strike Value-Based Deal for Entresto

Cigna reached an outcomes-based pact with Novartis for the company's heart failure drug Entresto.

February 1, 2016
CMS Publishes Long-Awaited 'AMP Rule'

CMS today published a final rule pertaining to Medicaid reimbursement for covered outpatient drugs. The rule, Medicaid Program; Covered Outpatient Drugs (81 Fed. Reg. 5169, Feb. 1, 2016), implements changes set forth in the Affordable Care Act. One key provision being finalized is the calculation of average manufacturer price (AMP) to establish federal upper limits for generic drug reimbursement to pharmacies. Download or view the rule here.

December 31, 2015
Prime Therapeutics Takes CVS to Court After Failed Arbitration

Prime Therapeutics sues CVS after failing to settle drug reimbursement discrepancy outside of court.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?